N-Methyl-D-aspartate (NMDA) Receptor NR1 Subunit Polyclonal Antibody

JHU scientists have developed a polyclonal antibody to the NR1 Subunit of the N-Methyl-D-aspartate (NMDA) Receptor. Proposed Use (Set) This technology encompasses an antibody specific for the NR1 Subunit of the NMDA Receptor. It has the potential to be commercialized as a biomarker for therapeutic, prophylactic or diagnostic use.

Inventor(s): Huganir, Richard

Type of Offer: Licensing

Next Patent »
« More Tools Patents

Share on      

CrowdSell Your Patent